From: A cross-sectional study of current work ability after radical prostatectomy
Variables | Moderate/poor work ability (N = 309) | High work ability (N = 421) | p-value | Total sample (N = 730) |
---|---|---|---|---|
Age at surgery, mean (SD) | 63.5 (5.6) | 61.8 (5.7) | < 0.001 | 62.5 (5.7) |
Clinical stage N (%) | 0.74 | |||
T1 – T2a | 198 (64) | 281 (67) | 479 (66) | |
T2b | 40 (13) | 49 (11) | 89 (12) | |
T3 | 71 (23) | 91 (22) | 162 (22) | |
Gleason scores, N (%) | 0.31 | |||
6 | 112 (36) | 175 (42) | 287 (39) | |
7 | 152 (49) | 185 (44) | 337 (46) | |
8–10 | 45 (15) | 61 (14) | 106 (15) | |
PSA. mean (SD) | 13.5 (15.5) | 12.3 (17.5) | 0.32 | 12.8 (16.7) |
D’Amico risk categories, N (%) | 0.16 | |||
Low | 61 (20) | 103 (24) | 164 (23) | |
Intermediate | 125 (40) | 176 (42) | 301 (41) | |
High | 123 (40) | 142 (34) | 265 (36) | |
Positive surgical margins, N (%) | 95 (31) | 1|12 (27) | 0.22 | 207 (28) |
Nerve sparing, N (%) | < 0.001 | |||
Bilateral | 61 (20) | 126 (30) | 187 (26) | |
Unilateral | 133 (43) | 195 (46) | 328 (45) | |
None | 115 (37) | 100 (24) | 216 (29) | |
Patological stage, N (%) | 0.24 | |||
pT2a – pT2c | 145 (47) | 216 (51) | 361 (49) | |
pT3a – pT3b | 164 (53) | 205 (49) | 369 (51) |